AU5086393A - Antisense oligonucleotides to cyclin d1 proto-oncogene - Google Patents
Antisense oligonucleotides to cyclin d1 proto-oncogeneInfo
- Publication number
- AU5086393A AU5086393A AU50863/93A AU5086393A AU5086393A AU 5086393 A AU5086393 A AU 5086393A AU 50863/93 A AU50863/93 A AU 50863/93A AU 5086393 A AU5086393 A AU 5086393A AU 5086393 A AU5086393 A AU 5086393A
- Authority
- AU
- Australia
- Prior art keywords
- proto
- cyclin
- oncogene
- antisense oligonucleotides
- antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3527—Other alkyl chain
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93507592A | 1992-08-25 | 1992-08-25 | |
US935075 | 1992-08-25 | ||
PCT/US1993/007892 WO1994004137A1 (en) | 1992-08-25 | 1993-08-23 | Antisense oligonucleotides to cyclin d1 proto-oncogene |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5086393A true AU5086393A (en) | 1994-03-15 |
Family
ID=25466557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50863/93A Abandoned AU5086393A (en) | 1992-08-25 | 1993-08-23 | Antisense oligonucleotides to cyclin d1 proto-oncogene |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5086393A (en) |
WO (1) | WO1994004137A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9506466D0 (en) * | 1994-08-26 | 1995-05-17 | Prolifix Ltd | Cell cycle regulated repressor and dna element |
DE19539130C2 (en) * | 1995-02-28 | 1999-05-12 | Max Planck Gesellschaft | Agents for the therapy of tumors and other hyperplasias |
EP1190047A1 (en) * | 1999-06-23 | 2002-03-27 | Angiogene, Inc. | Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof |
EP1436314A4 (en) * | 2002-02-20 | 2005-08-10 | Sirna Therapeutics Inc | Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina) |
-
1993
- 1993-08-23 WO PCT/US1993/007892 patent/WO1994004137A1/en active Application Filing
- 1993-08-23 AU AU50863/93A patent/AU5086393A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994004137A1 (en) | 1994-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5616394A (en) | Tampon applicator | |
AU5595194A (en) | Custom-fitting articles | |
EP0406309A4 (en) | Oligonucleotide n-alkylphosphoramidates | |
HU9402822D0 (en) | Antisense oligonucleotide inhibition of papillomavirus | |
AU623209B2 (en) | Theophylline dosage form | |
AU5568694A (en) | Stable oligonucleotides | |
AU4743093A (en) | Antisense polynucleotides | |
AU5953794A (en) | Tampon | |
AU5162993A (en) | Siloxy oligonucleotide analogs | |
AU1644788A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU3455393A (en) | Preparation for skin use | |
AU5086393A (en) | Antisense oligonucleotides to cyclin d1 proto-oncogene | |
AU5719094A (en) | Compartmented safe | |
EP0489846A4 (en) | Antisense oligonucleotides to c-abl proto-oncogene | |
GB2264216B (en) | Multi-share plough | |
AU1003188A (en) | Dopamine-beta-hydroxylase inhibitors | |
AU1370688A (en) | Dopamine-beta-hydroxylase inhibitors | |
GB2272770B (en) | Improvements to electrocardiagraphs | |
AU4975393A (en) | Improvements relating to earrings | |
AU5845594A (en) | Cancerous b cell treatment using substituted nucleoside derivatives | |
AU5136693A (en) | Antisense oligonucleotides to b myb proto-oncogene | |
EP0580795A4 (en) | Antisense oligonucleotides to c-kit proto-oncogene and uses thereof | |
AU3945493A (en) | Paired-ion oligonucleotides and methods for preparing same | |
AU6882087A (en) | Improvements in or relating to dispensers | |
AU640099B3 (en) | Improvements to shower trays |